Overcoming resistance to a standard chemotherapy drug

(Emory Health Sciences) Winship researchers identified an enzyme responsible for making tumors and cancer cell lines resistant to cisplatin, along with an experimental drug, lestaurtinib, which targets that enzyme.

Comments